Skip to main content
PeopleBio, Inc. logo

PeopleBio, Inc. — Investor Relations & Filings

Ticker · 304840 ISIN · KR7304840002 KO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2024-03-14 Proxy Solicitation & In…
Country KR South Korea
Listing KO 304840

About PeopleBio, Inc.

http://www.peoplebio.net/en/PEOPLEBIO.p…

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases. The company's primary focus is on degenerative brain disorders, particularly Alzheimer's disease. It develops blood-based diagnostic kits and immunoassays designed for early detection. By providing tools for early diagnosis, PeopleBio aims to facilitate timely intervention and treatment, thereby improving patient outcomes for these conditions.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by PeopleBio. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements and the election of directors and auditors. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and the matters to be voted upon.
2024-03-14 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted by PeopleBio regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the reasoning for choosing this date and acknowledges the regulatory guidelines regarding AGM dispersion. Since it is a regulatory notification regarding meeting logistics rather than the meeting materials themselves or the voting results, it falls under the general regulatory filing category.
2024-03-14 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for PeopleBio. It contains the meeting agenda, details on voting procedures (including electronic voting), and management reference materials (business overview, financial statements). This type of document is classified as a Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on company matters at the upcoming meeting.
2024-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (Proxy Solicitation). It contains information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures (electronic voting/proxy), and the company's financial statements for the fiscal year. While it contains financial data, the primary purpose of this specific document is to solicit proxies from shareholders for the AGM, making it a Proxy Solicitation & Information Statement.
2024-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (PeopleBio) announcing a significant change (over 30%) in its financial structure (revenue/profit/loss) compared to the previous fiscal year. This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial changes. Since it provides key financial highlights and is an initial announcement of financial results rather than a full annual report or a report publication announcement, it fits best under the 'Earnings Release' category. FY 2023
2024-02-05 Korean
[기재정정]반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'PeopleBio'. It contains detailed financial and operational information, including company overview, capital changes, and business purpose updates. It is a comprehensive financial report for a period shorter than a full fiscal year (the first half of 2023), which fits the definition of an Interim/Quarterly Report (IR). H1 2023
2023-11-30 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.